نمایش مختصر رکورد

dc.contributor.authorSoleimani, Nedaen_US
dc.contributor.authorTavakoli-Yaraki, Masoumehen_US
dc.contributor.authorFarhangi, Baharaken_US
dc.date.accessioned1399-07-08T19:07:41Zfa_IR
dc.date.accessioned2020-09-29T19:07:42Z
dc.date.available1399-07-08T19:07:41Zfa_IR
dc.date.available2020-09-29T19:07:42Z
dc.date.issued2016-07-01en_US
dc.date.issued1395-04-11fa_IR
dc.date.submitted2016-03-17en_US
dc.date.submitted1394-12-27fa_IR
dc.identifier.citationSoleimani, Neda, Tavakoli-Yaraki, Masoumeh, Farhangi, Baharak. (2016). Preparation and Evaluation anticancer activity of D-glucosamine Nanoparticles on Metastatic cancer Model in vivo. Nanomedicine Research Journal, 1(1), 53-58. doi: 10.7508/nmrj.2016.01.008en_US
dc.identifier.issn2476-3489
dc.identifier.issn2476-7123
dc.identifier.urihttps://dx.doi.org/10.7508/nmrj.2016.01.008
dc.identifier.urihttp://www.nanomedicine-rj.com/article_20607.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/59666
dc.description.abstract<br /><strong>Objective(s):</strong> Breast cancer imposes a highest rate of malignancy among the women all around the world. Chitin and its derivatives such as D-glucosamine-carboxymethyl chitin and Di-hydroxy propyl chitin have immune-modulating effects and influence on innate and acquisitive immunity which lead to cell activity enhancement. The aim of this study was investigating the effect of D-glucosamine nanoparticle on immune responses such as the changes in cytokines type 1 and 2 level in tumoral mice. <br /><br /><strong>Methods:</strong> Nanoparticles were synthesized by ionic gelation method and characterized by DLS and SEM methods. Tumors were induced in experimental mice and subsequently treated with nanoparticles. Then, the production of cytokine interferon-γ (IFN-γ) and interleukin 4 (IL-4) were evaluated. <br /><br /><strong>Results:</strong> The obtained results showed a significant increase in the level of IFN-γ production in the mice group treated with nanoparticles compared to control groups. Additionally, there was a reduction in the level of IL-4 and tumor size in the test group. <br /><br /><strong>Conclusions:</strong> D-glucosamine nanoparticles can be proposed as a stimulator of the immune system and a promising compound for cancer treatment in the future.en_US
dc.format.extent1262
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherIranian Society of Nanomedicineen_US
dc.relation.ispartofNanomedicine Research Journalen_US
dc.relation.isversionofhttps://dx.doi.org/10.7508/nmrj.2016.01.008
dc.subjectAnticancer activityen_US
dc.subjectD-glucosamine Nanoparticlesen_US
dc.subjectCanceren_US
dc.titlePreparation and Evaluation anticancer activity of D-glucosamine Nanoparticles on Metastatic cancer Model in vivoen_US
dc.typeTexten_US
dc.typeOriginal Research Articleen_US
dc.contributor.departmentDepartment of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iranen_US
dc.contributor.departmentDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iranen_US
dc.contributor.departmentDepartment of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iranen_US
dc.citation.volume1
dc.citation.issue1
dc.citation.spage53
dc.citation.epage58


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد